Literature DB >> 7935355

The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases.

J Beltman1, W K Sonnenburg, J A Beavo.   

Abstract

The cyclic nucleotide phosphodiesterases constitute a complex superfamily of enzymes responsible for catalyzing the hydrolysis of cyclic nucleotides. Regulation of cyclic nucleotide phosphodiesterases is one of the two major mechanisms by which intracellular cyclic nucleotide levels are controlled. In many cases the fluctuations in cyclic nucleotide levels in response to hormones is due to the hormone responsiveness of the phosphodiesterase. Isozymes of the cGMP-inhibited, cAMP-specific, calmodulin-stimulated and cGMP-binding phosphodiesterases have been demonstrated to be substrates for protein kinases. Here we review the evidence that hormonally responsive phosphorylation acts to regulate cyclic nucleotide phosphodiesterases. In particular, the cGMP-inhibited phosphodiesterases, which can be phosphorylated by at least two different protein kinases, are activated as a result of phosphorylation. In contrast, phosphorylation of the calmodulin-stimulated phosphodiesterases, which coincides with a decreased sensitivity to activation by calmodulin, results in decreased phosphodiesterase activity.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7935355     DOI: 10.1007/bf01076775

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  72 in total

1.  Molecular cloning of cDNA encoding a "63"-kDa calmodulin-stimulated phosphodiesterase from bovine brain.

Authors:  J K Bentley; A Kadlecek; C H Sherbert; D Seger; W K Sonnenburg; H Charbonneau; J P Novack; J A Beavo
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

2.  The catalytic subunit of protein kinase A triggers activation of the type V cyclic GMP-specific phosphodiesterase from guinea-pig lung.

Authors:  F Burns; I W Rodger; N J Pyne
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  Stimulation of the type III olfactory adenylyl cyclase by calcium and calmodulin.

Authors:  E J Choi; Z Xia; D R Storm
Journal:  Biochemistry       Date:  1992-07-21       Impact factor: 3.162

Review 4.  Molecular mechanisms involved in the antilipolytic action of insulin: phosphorylation and activation of a particulate adipocyte cAMP phosphodiesterase.

Authors:  V C Manganiello; C J Smith; E Degerman; V Vasta; H Tornqvist; P Belfrage
Journal:  Adv Exp Med Biol       Date:  1991       Impact factor: 2.622

5.  Evidence for domain organization within the 61-kDa calmodulin-dependent cyclic nucleotide phosphodiesterase from bovine brain.

Authors:  H Charbonneau; S Kumar; J P Novack; D K Blumenthal; P R Griffin; J Shabanowitz; D F Hunt; J A Beavo; K A Walsh
Journal:  Biochemistry       Date:  1991-08-13       Impact factor: 3.162

6.  Stimulation of a low Km phosphodiesterase from liver by insulin and glucagon.

Authors:  E G Loten; F D Assimacopoulos-Jeannet; J H Exton; C R Park
Journal:  J Biol Chem       Date:  1978-02-10       Impact factor: 5.157

7.  Regulation of cAMP concentration by calmodulin-dependent cyclic nucleotide phosphodiesterase.

Authors:  R K Sharma; J H Wang
Journal:  Biochem Cell Biol       Date:  1986-11       Impact factor: 3.626

8.  Differential regulation of bovine brain calmodulin-dependent cyclic nucleotide phosphodiesterase isoenzymes by cyclic AMP-dependent protein kinase and calmodulin-dependent phosphatase.

Authors:  R K Sharma; J H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

9.  Effects of selective phosphodiesterase inhibitors on isolated coronary, lung and renal arteries from man and rat.

Authors:  S Lindgren; K E Andersson
Journal:  Acta Physiol Scand       Date:  1991-05

10.  Molecular cloning and expression of human myocardial cGMP-inhibited cAMP phosphodiesterase.

Authors:  E Meacci; M Taira; M Moos; C J Smith; M A Movsesian; E Degerman; P Belfrage; V Manganiello
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

View more
  6 in total

1.  Allosteric-site and catalytic-site ligand effects on PDE5 functions are associated with distinct changes in physical form of the enzyme.

Authors:  Jackie D Corbin; Roya Zoraghi; Sharron H Francis
Journal:  Cell Signal       Date:  2009-08-06       Impact factor: 4.315

2.  Developmental signal transduction pathways uncovered by genetic suppressors.

Authors:  G Shaulsky; R Escalante; W F Loomis
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-24       Impact factor: 11.205

3.  D-myo-inositol 1,4,5-trisphosphate 3-kinase A is activated by receptor activation through a calcium:calmodulin-dependent protein kinase II phosphorylation mechanism.

Authors:  D Communi; V Vanweyenberg; C Erneux
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

4.  Distinctive anatomical patterns of gene expression for cGMP-inhibited cyclic nucleotide phosphodiesterases.

Authors:  R R Reinhardt; E Chin; J Zhou; M Taira; T Murata; V C Manganiello; C A Bondy
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

5.  Mutational activation of a Galphai causes uncontrolled proliferation of aerial hyphae and increased sensitivity to heat and oxidative stress in Neurospora crassa.

Authors:  Q Yang; K A Borkovich
Journal:  Genetics       Date:  1999-01       Impact factor: 4.562

6.  Prediction of secondary ionization of the phosphate group in phosphotyrosine peptides.

Authors:  M Wojciechowski; T Grycuk; J M Antosiewicz; B Lesyng
Journal:  Biophys J       Date:  2003-02       Impact factor: 4.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.